EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Steroidal nanoformulations for the treatment of uveitis: potential, promises and future perspectives

Pradip Nirbhavane, Gajanand Sharma, Rajeev Sharma, O P Katare

International Ophthalmology · 2024

DOI: 10.1007/s10792-024-03000-4 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Ophthalmology, 2024. Verfasst von Pradip Nirbhavane und 3 weiteren Autor:innen. Beteiligte Einrichtung: Amity University Haryana, Gurugram, 122413, India. pnirbhavane@ggn.amity.edu. Hauptthemen laut MEDLINE: Uveitis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 94 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Intraocular inflammation, commonly referred to as uveitis, is a prevalent ocular disease. The categorization of uveitis may be based on the prevailing anatomical site, which includes anterior, intermediate, and posterior uveitis. There exists a significant body of evidence indicating that T cells play a pivotal role in the pathogenesis of autoimmune uveitis. In addition to the presence of T cells, an elevation in levels of inflammatory cytokines and a reduction in regulatory cytokines were also noted. The primary pharmacological interventions for uveitis comprise of corticosteroids, methotrexate, anti-vascular endothelial growth factor (VEGF) agents, anti-tumor necrosis factor-alpha (TNF-α) antibodies, and sirolimus. These medications offer prompt alleviation for inflammation. Nevertheless, prolonged administration of corticosteroids invariably leads to unfavorable adverse reactions. The traditional topical corticosteroids exhibit certain limitations, including inadequate transcorneal permeation and low corneal retention, leading to reduced ocular bioavailability. Consequently, there is a growing inclination towards the creation of innovative steroid drug delivery systems with the aim of reducing the potential for adverse effects, while simultaneously enhancing the drug's corneal permeation and retention. CONCLUSION: This review is an attempt to compile all the research work done so far in this field and provides a brief overview of the global efforts to develop innovative nanocarrier-based systems for corticosteroids.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

UveitisHumansInflammationAdrenal Cortex HormonesTumor Necrosis Factor-alphaSteroids

Stichwörter der Autor:innen

Corneal permeationEye dropSteroidsUveitis

Substanzen

Adrenal Cortex HormonesTumor Necrosis Factor-alphaSteroids

Autor:innen und Institutionen

  • Amity University Haryana, Gurugram, 122413, India. pnirbhavane@ggn.amity.edu.
  • University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh, 160014, India.
  • Amity University, Gwalior, Madhya Pradesh, 474005, India.

Zitieren

APA

Nirbhavane, P., Sharma, G., Sharma, R., & Katare, O. P. (2024). Steroidal nanoformulations for the treatment of uveitis: potential, promises and future perspectives. International Ophthalmology. https://doi.org/10.1007/s10792-024-03000-4

Vancouver

Nirbhavane P, Sharma G, Sharma R, Katare OP. Steroidal nanoformulations for the treatment of uveitis: potential, promises and future perspectives. International Ophthalmology. 2024. doi:10.1007/s10792-024-03000-4

BibTeX
@article{Nirbhavane2024,
  author = {Nirbhavane, Pradip and Sharma, Gajanand and Sharma, Rajeev and Katare, O P},
  title = {Steroidal nanoformulations for the treatment of uveitis: potential, promises and future perspectives},
  journal = {International Ophthalmology},
  year = {2024},
  doi = {10.1007/s10792-024-03000-4}
}
Kostenlos starten →